Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:skincare_product
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:M-99_Saber
|
| gptkbp:affects |
sedation
analgesia |
| gptkbp:appointed_by |
injection
|
| gptkbp:approves |
1990s
|
| gptkbp:availability |
prescription only
|
| gptkbp:class |
gptkb:drug
|
| gptkbp:clinical_trial |
research purposes
conducted for safety conducted for efficacy wildlife immobilization zoo animal care |
| gptkbp:contraindication |
respiratory depression
|
| gptkbp:developed_by |
pharmaceutical companies
|
| gptkbp:dosage_form |
single-dose vials
multi-dose vials |
| gptkbp:duration |
varies by species
|
| gptkbp:emergency_services |
supportive care required
reversal agents available |
| gptkbp:formulation |
injectable solution
|
| gptkbp:frequency |
as needed
|
| https://www.w3.org/2000/01/rdf-schema#label |
M-99 B
|
| gptkbp:interacts_with |
opioids
anesthetics other sedatives |
| gptkbp:is_available_on |
vial
|
| gptkbp:is_monitored_by |
vital signs required
|
| gptkbp:is_used_for |
animal sedation
|
| gptkbp:legal_issue |
controlled substance
|
| gptkbp:lifespan |
variable
|
| gptkbp:manager |
subcutaneous
intramuscular |
| gptkbp:metabolism |
liver
|
| gptkbp:packaging |
multi-dose vials
|
| gptkbp:related_to |
M-99
|
| gptkbp:research |
gptkb:National_Park
animal behavior studies veterinary pharmacology |
| gptkbp:safety_features |
monitoring required
use in trained personnel |
| gptkbp:side_effect |
sedation
hypotension bradycardia overdose risk reversal agents available |
| gptkbp:storage |
room temperature
|
| gptkbp:targets |
domestic animals
exotic animals large mammals |
| gptkbp:training |
required for use
|
| gptkbp:used_in |
gptkb:hospital
|